Login
$SRPT
$15.38 +$0.25 (1.65%) Pre-market

Insider Transactions

What Sarepta Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 2
Total trades 4 49

Shares traded

3 months 12 months
Acquired 0 1,474,888
Disposed 81,519 132,523
Net activity −81,519 +1,342,365

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Rodino-Klapac Louise President, R&D and Tech Ops Sep 04 Withheld — tax / exercise cost · F −21,423 $22.22 −$476K 203,900
Rothfuss Cristin EVP, General Counsel Sep 04 Withheld — tax / exercise cost · F −22,025 $22.22 −$489K 115,519
Wong Ryan Ho-Yan Chief Financial Officer Sep 04 Withheld — tax / exercise cost · F −13,272 $22.22 −$295K 121,792
Estepan Ian Michael Chief Operating Officer Sep 04 Withheld — tax / exercise cost · F −24,799 $22.22 −$551K 177,184
Severino Michael Chief Executive Officer Jul 28 Grant / award · A +756,104 — — 756,104
Connelly Deirdre P Director Jun 04 Grant / award · A +16,875 — — 22,100
Barry Richard Director Jun 04 Grant / award · A +16,875 — — 2,983,542
Chambers Michael Andrew Director Jun 04 Grant / award · A +16,875 — — 27,535
Wigzell Hans Lennart Rudolf Director Jun 04 Grant / award · A +16,875 — — 42,098
Behrens M Kathleen Director Jun 04 Grant / award · A +16,875 — — 214,357
Mayo Stephen Director Jun 04 Grant / award · A +16,875 — — 18,640
Boor Kathryn Jean Director Jun 04 Grant / award · A +16,875 — — 25,138
Nicaise Claude Director Jun 04 Grant / award · A +16,875 — — 48,407
Mayo Stephen Director Mar 12 Sale for tax withholding · S −7,239 $17.02 −$123K 1,765
Wong Ryan Ho-Yan Chief Financial Officer Mar 11 Withheld — tax / exercise cost · F −256 $17.03 −$4.36K 135,064
Rodino-Klapac Louise President, R&D and Tech Ops Mar 11 Withheld — tax / exercise cost · F −948 $17.03 −$16.1K 225,323
Estepan Ian Michael Chief Operating Officer Mar 11 Withheld — tax / exercise cost · F −1,097 $17.03 −$18.7K 201,983
Rothfuss Cristin EVP, General Counsel Mar 11 Withheld — tax / exercise cost · F −974 $17.03 −$16.6K 137,544
Rothfuss Cristin EVP, General Counsel Mar 09 Withheld — tax / exercise cost · F −346 $16.95 −$5.86K 138,518
Wong Ryan Ho-Yan Chief Financial Officer Mar 09 Withheld — tax / exercise cost · F −113 $16.95 −$1.92K 135,320

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support